Prognostic Significance of Molecular Markers and Targeted Regimens in the Management of Acute Myeloid Leukemia
- PMID: 29784749
- DOI: 10.6004/jnccn.2018.0050
Prognostic Significance of Molecular Markers and Targeted Regimens in the Management of Acute Myeloid Leukemia
Abstract
The diagnosis, staging, and treatment of acute myeloid leukemia (AML) has evolved based on identification of important genetic alterations and drugs to target those genes. Cytogenetic abnormalities play a major role in managing AML. Achieving minimal residual disease is an increasingly important milestone. Four new targeted therapies are now available for the treatment of AML.
Copyright © 2018 by the National Comprehensive Cancer Network.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
